1. Home
  2. IZEA vs GBIO Comparison

IZEA vs GBIO Comparison

Compare IZEA & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZEA
  • GBIO
  • Stock Information
  • Founded
  • IZEA 2006
  • GBIO 2016
  • Country
  • IZEA United States
  • GBIO United States
  • Employees
  • IZEA N/A
  • GBIO N/A
  • Industry
  • IZEA Advertising
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • IZEA Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • IZEA Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • IZEA 44.6M
  • GBIO 29.2M
  • IPO Year
  • IZEA N/A
  • GBIO 2020
  • Fundamental
  • Price
  • IZEA $3.42
  • GBIO $0.52
  • Analyst Decision
  • IZEA
  • GBIO Strong Buy
  • Analyst Count
  • IZEA 0
  • GBIO 4
  • Target Price
  • IZEA N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • IZEA 58.2K
  • GBIO 1.8M
  • Earning Date
  • IZEA 08-13-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • IZEA N/A
  • GBIO N/A
  • EPS Growth
  • IZEA N/A
  • GBIO N/A
  • EPS
  • IZEA N/A
  • GBIO N/A
  • Revenue
  • IZEA $36,896,490.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • IZEA $16.46
  • GBIO N/A
  • Revenue Next Year
  • IZEA $15.95
  • GBIO N/A
  • P/E Ratio
  • IZEA N/A
  • GBIO N/A
  • Revenue Growth
  • IZEA 7.17
  • GBIO 146.47
  • 52 Week Low
  • IZEA $1.68
  • GBIO $0.30
  • 52 Week High
  • IZEA $3.52
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • IZEA 77.25
  • GBIO 66.42
  • Support Level
  • IZEA $2.55
  • GBIO $0.32
  • Resistance Level
  • IZEA $3.15
  • GBIO $0.59
  • Average True Range (ATR)
  • IZEA 0.17
  • GBIO 0.05
  • MACD
  • IZEA 0.08
  • GBIO 0.02
  • Stochastic Oscillator
  • IZEA 89.71
  • GBIO 76.34

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: